Cargando…

Gerofit Decreases Medication Use Among Older Veterans

We examined whether Veterans enrolled in Gerofit for at least 12 months between 10/2012-3/2017 saw reductions in their medication utilization (5 sites, 226 Veterans). VA outpatient pharmacy data was used to identify medications used 12-months prior, and 12-months following Gerofit enrollment. Seven...

Descripción completa

Detalles Bibliográficos
Autores principales: Intrator, Orna, Li, Jiejin, Veazie, Peter, Wesgate, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7742638/
http://dx.doi.org/10.1093/geroni/igaa057.2789
_version_ 1783624035002744832
author Intrator, Orna
Li, Jiejin
Veazie, Peter
Wesgate, Sara
author_facet Intrator, Orna
Li, Jiejin
Veazie, Peter
Wesgate, Sara
author_sort Intrator, Orna
collection PubMed
description We examined whether Veterans enrolled in Gerofit for at least 12 months between 10/2012-3/2017 saw reductions in their medication utilization (5 sites, 226 Veterans). VA outpatient pharmacy data was used to identify medications used 12-months prior, and 12-months following Gerofit enrollment. Seven drug classes were identified (cardiovascular, diabetic, lipid, mental health, opioids, vitamins, other medications). Nearest-neighbor propensity-matched analyses was conducted with exact match on number of baseline medications and site. At baseline, Gerofit participants were taking, on average, 11.6 medications (1.7 cardiovascular, 0.6 diabetes, 0.7 lipid lowering, 0.7 mental health, 0.5 opioids, 0.6 vitamins, 7.0 other). At 12-month follow-up, Gerofit patients were taking fewer medications: any (-2.7 [-4.4, -1.0]); cardiovascular (-0.5 [-0.7, -0.3]); diabetes (-0.7 [-1.2, -0.2]); mental health (-0.9 [-1.5, -0.2]); and other (-2.4 [-3.5, -1.4]) compared to matched comparisons. No significant differences at 12-months were found for lipid lowering, opioids, or vitamins. Conclusion: Gerofit participation reduced medication use.
format Online
Article
Text
id pubmed-7742638
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77426382020-12-21 Gerofit Decreases Medication Use Among Older Veterans Intrator, Orna Li, Jiejin Veazie, Peter Wesgate, Sara Innov Aging Abstracts We examined whether Veterans enrolled in Gerofit for at least 12 months between 10/2012-3/2017 saw reductions in their medication utilization (5 sites, 226 Veterans). VA outpatient pharmacy data was used to identify medications used 12-months prior, and 12-months following Gerofit enrollment. Seven drug classes were identified (cardiovascular, diabetic, lipid, mental health, opioids, vitamins, other medications). Nearest-neighbor propensity-matched analyses was conducted with exact match on number of baseline medications and site. At baseline, Gerofit participants were taking, on average, 11.6 medications (1.7 cardiovascular, 0.6 diabetes, 0.7 lipid lowering, 0.7 mental health, 0.5 opioids, 0.6 vitamins, 7.0 other). At 12-month follow-up, Gerofit patients were taking fewer medications: any (-2.7 [-4.4, -1.0]); cardiovascular (-0.5 [-0.7, -0.3]); diabetes (-0.7 [-1.2, -0.2]); mental health (-0.9 [-1.5, -0.2]); and other (-2.4 [-3.5, -1.4]) compared to matched comparisons. No significant differences at 12-months were found for lipid lowering, opioids, or vitamins. Conclusion: Gerofit participation reduced medication use. Oxford University Press 2020-12-16 /pmc/articles/PMC7742638/ http://dx.doi.org/10.1093/geroni/igaa057.2789 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Intrator, Orna
Li, Jiejin
Veazie, Peter
Wesgate, Sara
Gerofit Decreases Medication Use Among Older Veterans
title Gerofit Decreases Medication Use Among Older Veterans
title_full Gerofit Decreases Medication Use Among Older Veterans
title_fullStr Gerofit Decreases Medication Use Among Older Veterans
title_full_unstemmed Gerofit Decreases Medication Use Among Older Veterans
title_short Gerofit Decreases Medication Use Among Older Veterans
title_sort gerofit decreases medication use among older veterans
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7742638/
http://dx.doi.org/10.1093/geroni/igaa057.2789
work_keys_str_mv AT intratororna gerofitdecreasesmedicationuseamongolderveterans
AT lijiejin gerofitdecreasesmedicationuseamongolderveterans
AT veaziepeter gerofitdecreasesmedicationuseamongolderveterans
AT wesgatesara gerofitdecreasesmedicationuseamongolderveterans